Top 30 Biotechnology Angel Investors in China (October 2026)

Portfolio highlights

• MacroLux — MacroLux Medical Technology Co., Ltd.
• Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
• Xiwei Biotechnology — Xiwei Biotechnology is an ophthalmology implanted medical device developer that specializes in the unique product development of new bio-modified materials for ocular implantable medical devices and regenerative medicine.

Portfolio highlights

• Wuwai Zhiqu — Wuwai Zhiqu is a developer of wearable hardware for early childhood education. Through its self-developed proactive multimodal AI Agent architecture, it can record and understand children's daily life scenarios in real time.
• Blue Emergence — Blue Emergence is a marine technology consumer products company,
• Xunlu Innovation — Xunlu Innovation is a cutting-edge bicycle manufacturer based in Shenzhen, China, specializing in intelligent electric cargo bikes designed to meet modern urban mobility needs.

Portfolio highlights

• Yiweisen — Yiweisen is a research and development firm that manufactures functional natural compound raw materials.

Portfolio highlights

• Genefun — Genefun is a genetic testing service and health management solution provider.

Portfolio highlights

• Allygen Biologics — Allygen Biologics is a biotechnology company that provides research and development of targeted conjugate therapeutics.
• Genepoint Biological Technology — Genepoint Biological Technology is a healthcare Company.

Portfolio highlights

• Zenshine Pharma — Zenshine Pharma is a clinical-stage biopharmaceutical company with a focus on the development of small molecule drugs for cancer, viral infections, and autoimmune diseases.
• Human Zhizao — Human Intelligent Manufacturing is a fully automatic multiple flow fluorescence platform.
• GenMedicn Biopharma — GenMedicn is a gene therapy drug development company dedicated to popularizing gene therapy drugs to normalized application scenarios.

Portfolio highlights

• SyMap Medical — SyMap is dedicated to developing a proprietary, catheter-based renal mapping and ablation system for renal denervation therapy to treat hypertension and other diseases, such as heart failure, arrhythmia, and renal failure.

Portfolio highlights

• SyMap Medical — SyMap is dedicated to developing a proprietary, catheter-based renal mapping and ablation system for renal denervation therapy to treat hypertension and other diseases, such as heart failure, arrhythmia, and renal failure.

Portfolio highlights

• Gongye Technology — Gongye Technology makes use of AI and big data to manufacture intelligent equipment for solid waste sorting and recycling.
• Zechuang Tiancheng — Zechuang Tiancheng is a SaaS-level clinical research digital platform to provide solutions for clinical research.
• Lianyuan Intelligence — Shanghai Lianyuan Intelligent is an innovative energy Internet comprehensive value-added service provider jointly invested by the world's leading new energy companies and executives of the world's top 500 power industry and consulting companies.

Portfolio highlights

• Jimi Bio — Jimo Bio is a research and development company of cell-cultured meat.

Portfolio highlights

• Maitong Biopharmaceutical — Maitong Bio is an anti-tumor drug developer it engages in the development of new small molecule targeted anti-tumor drugs.

Portfolio highlights

• Renjing Biology — Renjing Biotech is committed to the research and development of innovative drugs based on messenger ribonucleic acid (mRNA).

Portfolio highlights

• Alioth — Elios focuses on the development and application of technical products for pharmaceutical process technology.

Portfolio highlights

• Lyxia China — Lyxia is a biotechnology corporation founded in the State of Delaware at 2012, providing a pioneer technology platform to harness the prolific biofuel yield from microalgae. Lyxia:registered: homes in the desired breakthrough for the current bottleneck of large scale fuel and protein production, and further turns these renewable resource intocommercial oil.
• Hommily — Hommily is a new peer to peer social travel network helping connect travelers to locals from around the globe. Hommily makes it easy to connect with locals for tours, events, drivers, and activities during your trip.
• Quivr — Quivr empowers you to take control of your digital identity, making it easier to connect with a community that truly shares your passions and values.

Portfolio highlights

• MingCeler — MingCeler is a Bio-Island Laboratory incubation enterprise focused on developing TurboMice™ tetraploid compensation technology. It provides high-end, fast, and excellent model biological technology services and resources for pharmaceutical companies, vaccine companies, universities, research institutes, hospitals, and other life and health-relatedresearch teams.

Portfolio highlights

• NeoCura — NeoCura provides an AI platform to collect and analyze molecular biology data and clinical data, enabling physicians to make improve the diagnosis and treatment of cancer patients.

Portfolio highlights

• Tai'an Hanwei Group — Tai'an Hanwei Group is a research company that develops and produces biopharmaceuticals and nutritional products.

Portfolio highlights

• Ruier Weikang — Ruier Weikang focuses on the development and commercialization of brain scientific disease diagnostic, monitoring, and therapy products.

Portfolio highlights

• Imbioray — Imbioray is a biotechnology company that specializes in cellular immunotherapy for tumors and immune diseases. The company engages in the development of global CAR-NK and tiNK cell therapy drugs and is committed to solving the treatment of clinically unmet diseases.
• Torrey Pines Medicine — Torrey Pines Medicine is a biotechnology business focused on creating next-generation ultra-long-acting peptide therapies for metabolic illnesses.

Portfolio highlights

• Zion Pharma — Zion is a leading drug discovery platform that develops "me-better" drugs that address true unmet needs.

Portfolio highlights

• Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.

Portfolio highlights

• Boyi Biotechnology — Boyi Biotechnology is a technology-based firm that provides vital raw materials and complete solutions to biomedical customers in the in vitro diagnostic market. It focus on diagnostic microspheres, testing raw materials, and quality control products.

Portfolio highlights

• Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.

Portfolio highlights

• PAM2L Biotechnologies — Boyin Bio is an innovative biomaterial research and development and application enterprise.
• May Micromarketing — May Micromarketing is a beauty short video MCN organization with a team of people, editors, editors and operations. In the logic of the Redskins, May Beauty is mainly to learn from the existing explosions, and to make original content for their own characteristics and advantages.

Portfolio highlights

• KMAX — KMAX specializes in AR and VR content research and development. It has independently developed core technologies such as real-time 3D modeling, 3D generalized cloud connection, cloud VR resource rendering, and an editing engine.
• Snow Origin — Snow Origin is a Beijing deep-tech company specializing in neural interfaces and surface EMG (sEMG) interaction. They build BCI peripheral hardware to deliver natural, stable human-computer interaction for next-generation AR/VR headsets and smart devices.
• CapitalBio Pharma — CapitalBio Pharma is a biotechnology company that specializes in innovative medicines to empower precise diagnosis and treatment. It is a subsidiary of CapitalBio Corporation.

Portfolio highlights

• St Phi Therapeutics — Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy.
• Hengyu Biotechnology — Hengyu Biotechnology is a CXO platform founded by a scientific research team that provides biosafety testing and related process validation.

Portfolio highlights

• Zeno Biotech — Zeno Technology is a technologically advanced business that concentrates on harnessing synthetic biology to produce natural products with added value. It has created items using fermentation engineering and synthetic biology. The company primarily targets Saccharomyces cerevisiae, E. coli, and other chassis microorganisms genetically usingnew-generation gene editing technology like CRSPR-Cas9, as well as industrializing the by-products of these strains through fermentation and isolation methods.

Portfolio highlights

• Weiyuan Synthetic Biotechnology — Weiyuan Synthetic Biotechnology specializes in the manufacturing of food, feed and materials based on synthetic biology technology.

Portfolio highlights

• Giant Microbiology — Giant Microbiology is a company that produces synthetic biological raw materials in an environmentally friendly manner for the fields of beauty and daily chemicals, functional foods, and medical beauty.. The business focuses on creating "high-gross-profit innovative products" that satisfy consumer demand and offer useful, cutting-edge rawmaterial solutions, with bioactive sugars serving as its starting point. Hyaluronic acid, oligosaccharides, and functional oligosaccharides are among the goods it primarily develops and produces.

Portfolio highlights

• Sconray Biotech — Sconray Biotech is a green biotechnology company focusing on synthetic biology and green science. Their products include NAD+, 5-ALA, and diversified ones used in medicine, food, healthcare, daily chemicals, and agriculture.